Your Article Summary
See Latest ArticlesThe hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials
Current Medical Research and Opinion, 06/25/09
Soni P et al. - In this pooled analysis, the incidence of hepatic AEs in patients treated with celecoxib was similar to that for both placebo-treated patients and patients treated with ibuprofen or naproxen, but lower than for diclofenac.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09
Annual Progression of Coronary Calcification in Trials of Preventive Therapies
Archives of Internal Medicine, 12/15/09
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6ยท4 years
The Lancet, 12/15/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09
Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer
The Journal of Thoracic and Cardiovascular Surgery, 12/15/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09